NEO
NeoGenomics, Inc. · NASDAQ
- Sector Health Services
- Industry Medical/Nursing Services
- Website neogenomics.com
- Employees(FY) 2100
- ISIN US64049M2098
Performance
-4.52%
1W
+6.86%
1M
+3.06%
3M
-17.64%
6M
-8.53%
YTD
-19.13%
1Y
Profile
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. The company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization, as well as acts as a reference laboratory supplying anatomic pathology testing services. It has a strategic alliance agreement and laboratory services agreement with Inivata Limited. The company was founded in 2001 and is headquartered in Fort Myers, Florida.
Investment Analysis Report: NEO
Overview
In this investment analysis report, we will delve into the financial statements of NEO, a company operating in the Health Services sector within the Medical/Nursing Services industry. We will analyze the company's financial health, earnings and revenue growth, profitability, operating margin, operating ca...
Technical Analysis of NEO 2024-05-10
Overview:
In analyzing the technical indicators for NEO over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key aspects, we aim to offer valuable insights and predictions for potential investo...
Recent News & Updates
- 2024-05-02 14:14
NeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript(Insider Monkey)
- 2024-05-02 06:14
- 2024-05-02 02:14
- 2024-05-01 03:04
- 2024-04-30 11:25
- 2024-04-30 10:30
- 2024-04-30 08:52
- 2024-04-30 08:40
- 2024-04-30 07:37
NeoGenomics: Q1 Earnings Snapshot(Associated Press Finance)
- 2024-04-30 07:30
NeoGenomics Reports First Quarter 2024 Results(Business Wire)
- 2024-04-29 23:53
- 2024-04-29 22:30
- 2024-04-29 20:40
- 2024-04-29 19:30
NeoGenomics Reports First Quarter 2024 Results(Businesswire)
- 2024-04-24 10:01
- 2024-04-23 20:00
NEO: What does Argus have to say about NEO?(Argus Research)
- 2024-04-23 10:00
- 2024-04-22 22:00
- 2024-04-18 07:05
NeoGenomics Announces Senior Leadership Promotions(Business Wire)
- 2024-04-17 19:05
NeoGenomics Announces Senior Leadership Promotions(Businesswire)
- 2024-04-10 11:07
- 2024-04-09 07:00
- 2024-04-08 19:00
- 2024-03-27 08:30
- 2024-03-26 20:30
- 2024-03-20 12:00
- 2024-03-20 09:55
- 2024-03-20 07:00
- 2024-03-20 00:00
- 2024-03-19 21:55
Page 1 of 6
previousnext